The Effect of Intravenous Iron Therapy and Erythropoiesis-stimulation Agent Combination on Renal Transplant Outcomes
Condition(s):Kidney Failure, ChronicLast Updated:February 9, 2023Not yet recruiting
Hide Studies Not Open or Pending
Condition(s):Kidney Failure, ChronicLast Updated:February 9, 2023Not yet recruiting
Condition(s):End Stage Renal Disease on DialysisLast Updated:August 30, 2021Unknown status
Condition(s):Chronic Kidney Disease(CKD); Uncontrolled HypertensionLast Updated:October 30, 2023Recruiting
Condition(s):Kidney Failure, ChronicLast Updated:March 14, 2023Completed
Condition(s):Kidney Failure, Chronic; Peritoneal Dialysis ComplicationLast Updated:May 3, 2023Completed
Condition(s):Hemodialysis Complication; Hypotension of HemodialysisLast Updated:August 18, 2023Recruiting
Condition(s):Chronic Kidney DiseasesLast Updated:December 15, 2023Completed
Condition(s):End-stage Kidney Disease; Diabetes Mellitus; Arteriovenous FistulaLast Updated:February 19, 2019Completed
Condition(s):Acute Kidney Injury; Chronic Kidney Diseases; Solid-organ Transplantation; Cancer; Metabolic Disease; Immune DiseasesLast Updated:December 7, 2022Recruiting
Condition(s):End Stage Renal Disease; HyperphosphatemiaLast Updated:August 24, 2018Unknown status
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.